论文部分内容阅读
作者自2000年6月起对90例急性脑梗死患者分别使用尿激酶和东菱克栓酶治疗,现将结果报告如下。1临床资料90例患者均符合1995年全国第四届脑血管会议制定的诊断标准,且具备下列条件:首次发病,起病在12 h内;非昏迷患者;血压控制在180/100 mmHg以下;无出血及凝血障碍倾向;未用其它
Since June 2000 on 90 patients with acute cerebral infarction patients were treated with urokinase and tangling bolt enzyme, the results are reported as follows. 1 Clinical data 90 patients were in line with the 1995 Fourth National Conference on Cerebrovascular Disease diagnostic criteria, and have the following conditions: the first onset, onset within 12 h; non-coma patients; blood pressure control in 180/100 mmHg or less; No bleeding and coagulopathy tendency; not used other